This Library Guide (LibGuide) is a collection of useful documents & evidence on the pentavalent meningococcal ACWYX conjugate vaccine (Men5CV) which was prequalified by the World Health Organization (WHO) in July 2023.
The WHO's "Defeating Meningitis by 2030" global roadmap aims to eliminate bacterial meningitis epidemics, reduce cases of vaccine-preventable bacterial meningitis by 50% and deaths by 70%, and improve quality of life for those affected by meningitis.
The prequalification of the novel pentavalent (Men5CV) vaccine by the WHO, and subsequent recommendation for incorporation into routine immunization programs has the potential to eradicate meningitis.
Men5CV is a vaccine that protects against five strains of meningococcal bacteria, specifically serogroups A, C, W, and Y, and also serogroup X. Nigeria was the first country to roll out the new Men5CV vaccines.
Start exploring
The LibGuide: Pentavalent Meningococcal Conjugate Vaccine is also available full-screen at UCT Libraries.